Ignyta Expands Clinical Leadership Team With Appointments Of Pratik Multani, M.D., M.S., As Chief Medical Officer And Adrian Senderowicz, M.D., As Clinical And Regulatory Strategy Officer

Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, announced today that Pratik S. Multani, M.D., M.S., has been appointed as Chief Medical Officer, assuming responsibility for the role from Adrian Senderowicz, M.D., who has been appointed to the newly-created role of Clinical and Regulatory Strategy Officer.

Help employers find you! Check out all the jobs and post your resume.